Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

Fig. 1

Levels of glycated albumin (GA) and oxidized low-density lipoprotein (oxLDL) in insulin-treated and non-insulin-treated groups measured before and after treatment. a GA levels in the non-treated group (n = 7), non-insulin-treated group (n = 16) and the insulin-treated group (n = 12). b Serum levels of oxLDL in the non-insulin group (n = 22) and insulin-treated group (n = 11). Data are the mean ± standard error of the mean. *P < 0.05 vs. values before treatment

Back to article page